SNCE
Science 37 is a leading clinical research company focused on expanding trial access by delivering direct-to-patient, hybrid, and decentralized clinical trials. It provides patient-and site-centric solutions, including a FDA-inspected Direct-to-Patient Site, patient recruitment, and research-grade nursing to support enrollment and data collection. Headquartered to serve global sponsors and investigators, the company emphasizes reaching diverse patient populations and bringing clinical research to patients’ homes or local settings for faster, more inclusive trials.
No recent news for this company.
No recent deals for this company.